Open the mobile version, with barcode scanning
Class II Terminated

Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01

Why: Presence of Particulate Matter: Silicone oil

Company
HOSPIRA INC, LAKE FOREST
LAKE FOREST, IL, United States
Reported
Aug 16, 2017
Recall started
Jul 26, 2017
Ended
May 11, 2018
Where sold
Nationwide in the USA
Amount
14,300 vials
Full product description
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Lots / codes affected
Lot #: 560053F, Exp. 01AUG2017

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.